Cleerly LABS vs FEops HEARTguideTM
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary goal is to thoroughly assess and monitor coronary artery disease (CAD) through detailed plaque characterization and stenosis quantification from CCTA scans. This tool is ideal for identifying patients at risk, guiding medical management strategies, and tracking disease progression over time to personalize preventive care.
View Cleerly LABS →Choose FEops HEARTguideTM if…
Choose FEops HEARTguideTM if you require advanced pre-procedural planning for complex structural heart interventions such as TAVI or LAAO. This platform excels at providing predictive simulations and precise anatomical measurements from CT scans to optimize device sizing, positioning, and overall procedural strategy, aiming to enhance patient outcomes.
View FEops HEARTguideTM →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | FEops HEARTguideTM |
|---|---|---|
| Pricing | Per analysis | Contact for pricing |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS is described as an interactive web-based software where trained medical professionals directly view, analyze, and edit segmentations of coronary CT angiography data. While FEops HEARTguide also offers an interactive viewer and manual measurement options, its service-based model implies that FEops prepares the initial analysis, potentially offering less direct user control over the core AI analysis process itself.
Clinical Value
TieBoth tools offer significant and distinct clinical value. Cleerly LABS provides comprehensive diagnostic and prognostic insights for coronary artery disease, with strong clinical validation for ischemia detection and prediction of major adverse cardiovascular events. FEops HEARTguide significantly enhances the planning and outcomes of complex structural heart interventions like TAVI and LAAO through predictive simulations, demonstrating improved procedural efficiency and favorable clinical outcomes. Their contributions are equally impactful in different areas of cardiac care.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing information, including a per-analysis cost, retail price, and details on insurance coverage and potential out-of-pocket expenses. In contrast, FEops HEARTguide's pricing is not publicly disclosed, requiring direct contact for details, which makes it challenging for potential users to assess its value upfront.
Enterprise Readiness
FEops HEARTguideTMBoth tools are FDA-cleared, HIPAA compliant, and offer BAA, cloud-based deployment, and integration with clinical workflows. However, FEops HEARTguide explicitly mentions advanced security features like multi-factor authentication and enforced password changes, which are crucial for robust enterprise security and demonstrate a comprehensive approach to data protection within a hospital system.
Innovation
FEops HEARTguideTMWhile Cleerly LABS is highly innovative with its AI-powered comprehensive plaque and ischemia analysis and has received multiple industry awards, FEops HEARTguide's 'digital twin' technology for predictive simulations in structural heart interventions represents a more novel and complex application of AI and computational modeling. This patient-specific virtual replica approach to simulate device-anatomy interaction for pre-operative planning is a cutting-edge advancement in personalized interventional cardiology.
Support & Docs
Cleerly LABSCleerly LABS provides clear information regarding its client support, including specific operating hours (Monday-Friday, 10 am ET to 6 pm ET) and a dedicated channel for existing users to request technical assistance. FEops HEARTguide mentions a support email and a 'Documentation' page, but lacks the specific details on availability and structured support processes that Cleerly offers.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | FEops HEARTguideTM |
|---|---|---|
| Tool Name | Cleerly LABS | FEops HEARTguideTM |
| Company | Cleerly | FEops nv |
| Primary Focus / Use Case | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | Structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. |
| Key Technology | AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module). | AI and digital twin platform, predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements from CT scans. |
| Data Integration | Integration with PACS, RIS, EHR via Cleerly Proxy. | DICOM interface for easy integration into clinical workflow. |
| Visualization Capabilities | 3D visualization of coronary arteries. | Interactive 2D and 3D viewer for detailed analysis, visualization and image reconstruction techniques (2D review, MPR). |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and FEops HEARTguideTM.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or FEops HEARTguideTM
Backers
Who funded each tool's parent company.